Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
05/2012
05/09/2012EP1609798B1 Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof
05/09/2012EP1501467B1 Heterocyclo inhibitors of potassium channel function
05/09/2012EP1480960B1 Substituted 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-ones, the production thereof and their use in medicaments
05/09/2012EP1423107B1 Fatty alcohol drug conjugates
05/09/2012CN1861099B Snake oil soft capsule
05/09/2012CN102449148A Ss-galactosidase derived from bacillus circulans
05/09/2012CN102448949A Heterocyclic compound and hematopoietic stem cell amplifier
05/09/2012CN102448479A A novel antidiabetic furostanolic saponin rich (fsr) fraction from fenugreek seeds
05/09/2012CN102448478A Use of probiotics to ameliorate diet-induced insulin resistance
05/09/2012CN102448477A Use of a probiotic to regulate body weight
05/09/2012CN102448466A New therapeutical uses of inecalcitol
05/09/2012CN102448456A Methods for preventing major adverse cardiovascular events with dpp-iv inhibitors
05/09/2012CN102448453A Use of PUFAS to treat nerve damage
05/09/2012CN102448445A Orally disintegrating coated tablet
05/09/2012CN102443582A Gene for promoting insulin secretion, its preparation method and application
05/09/2012CN102443528A Wolfberry yam wine and preparation method thereof
05/09/2012CN102443074A Pectin preparation method
05/09/2012CN102443064A Thrombin activity based chimeric peptide with double targeting effects and application thereof
05/09/2012CN102442997A Quinoline derivative as well as preparation method thereof, midbody and application thereof
05/09/2012CN102442918A Stable levocarnitine compound
05/09/2012CN102441156A Traditional Tibetan medicinal composition and preparation method thereof
05/09/2012CN102441118A Application of medicinal composition in preparing medicaments for treating diabetes mellitus and impaired glucose tolerance
05/09/2012CN102441096A Novel blood stasis elimination and collaterals dredging compound pill and preparation method thereof
05/09/2012CN102441064A Traditional Chinese medicine composition for treating diabetes and preparation thereof
05/09/2012CN102441051A Extraction process for flavedo flavone
05/09/2012CN102441026A Fenugreek flavonoids extract preparation method and blood sugar level decreasing application thereof
05/09/2012CN102441019A Chinese medicinal chrysanthemum buccal tablet
05/09/2012CN102441009A Natural extraction method of pearl active substance
05/09/2012CN102441000A Anti-cancer anti-disease buccal tablet
05/09/2012CN102440999A Compound drug for preventing and curing iron-deficiency anemia and low anaphylaxis
05/09/2012CN102440989A Compound amino acid injecta, and preparation method and detection method thereof
05/09/2012CN102440976A Epalrestat slow-release tablet and preparation method thereof
05/09/2012CN102440975A Metformin hydrochloride sustained-release tablets and preparation method thereof
05/09/2012CN102440972A Gliclazide tablet (II) and preparation method thereof
05/09/2012CN102440966A Preparation process research of exenatide slow-release preparation
05/09/2012CN102440952A Iron-dextrin long-acting injection and preparation method thereof
05/09/2012CN102440949A Preparation method of fructose injection
05/09/2012CN102440940A Bath salt with functions of losing weight and moistening skin
05/09/2012CN102151296B Method for extracting active ingredients for reducing sugar blood from waste residues of liquorice
05/09/2012CN101961401B Compound Chinese medicinal composition having effects of reducing weight, reducing fat, tonifying spleen and beautifying
05/09/2012CN101953948B Medicine used for curing diabetes of deficiency of Qi-Yin syndrome
05/09/2012CN101884723B Anemarrhena and goldthread composition preparation used for treating diabetes and preparation method thereof
05/09/2012CN101818133B VSIG4 (V-set and Ig domain containing 4) and IGRP (glucose-6-phosphatase catalytic subunit-related protein) dual-gene coexpression recombinant adenovirus as well as preparation method and application thereof
05/09/2012CN101816770B Chinese medicinal composition for treating diabetes and preparation method thereof
05/09/2012CN101810663B Use of yuenkanin extract for preparing slimming blood lipid-lowering medicine
05/09/2012CN101724589B Method for microencapsulating cholesterol-degrading lactic acid bacteria
05/09/2012CN101691394B Method for solid phase synthesis of bitter gourd MC-JJ6 peptide analogs under microwave irradiation and application of bitter gourd MC-JJ6 peptide analogs
05/09/2012CN101633644B N3 alkylated benzimidazole derivatives as mek inhibitors
05/09/2012CN101590033B Medicinal composition fat emulsion injection containing eucalyptol, limonene and alpha-pinene and preparation method
05/09/2012CN101564511B Natural protein product for treating diabetes and manufacture method
05/09/2012CN101538323B Method for purifying Exenatide
05/09/2012CN101530466B Nano medicament containing oregano oil and vitamins
05/09/2012CN101439059B Ginkgo leaf extract drop and preparation method thereof
05/09/2012CN101348482B 3-amido-4-indole maleimide compound, preparation and use thereof
05/09/2012CN101347240B Health food
05/09/2012CN101332229B Prunella plant extract and pharmaceutical use thereof
05/09/2012CN101274953B Method for extracting corosolic acid from plant
05/08/2012US8173807 Pyridine, pyrimidine and pyrazine derivatives as GPCR agonists
05/08/2012US8173782 Fusion protein comprising growth hormone and growth hormone receptor
05/08/2012US8173663 Dipeptidyl peptidase inhibitors
05/08/2012US8173654 Triazolopyridazine compounds
05/08/2012US8173649 Glucokinase activator
05/08/2012US8173145 Formulation containing phosphate derivatives of electron transfer agents
05/08/2012US8173142 Pharmaceutical compositions of drugs and neutralized acidic polymers
05/08/2012US8173129 Methods and compositions for treating autoimmune diseases
05/08/2012CA2561628C Histamine h3 receptor agents, preparation and therapeutic uses
05/08/2012CA2518205C Use of a fibrate and orlistat for the treatment of obesity
05/08/2012CA2514356C Novel inhibitors of formation of advanced glycation endproducts (ages)
05/08/2012CA2513660C Hydroxyl compounds and compositions for cholesterol management and related uses
05/08/2012CA2469334C Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation
05/08/2012CA2388041C High mannose proteins and methods of making high mannose proteins
05/08/2012CA2353574C Analogues of glp-1
05/08/2012CA2229741C Functional role of adrenomedullin (am) and the gene-related product (pamp) in human pathology and physiology
05/03/2012WO2012058276A2 Methods and materials for reducing mutiple risk factors associated with the metabolic syndrom
05/03/2012WO2012057291A1 Process for production of phenolic polymerizable compound having physiological activity
05/03/2012WO2012057103A1 Pharmaceutical composition
05/03/2012WO2012056509A1 Pharmaceutical composition
05/03/2012WO2012056229A1 Inflammatory disease
05/03/2012WO2012056113A1 Composition and method for influencing energy metabolism and treating metabolic and other disorders
05/03/2012WO2012056024A1 Composition comprising a combination of at least one proteolytic enzyme and at least one lipolytic enzyme, for use in preventing triglyceride synthesis
05/03/2012WO2012055770A1 Glucose-dependent insulinotropic peptide analogs
05/03/2012WO2012055577A1 An edible product
05/03/2012WO2012055169A1 C-arylglucoside derivative, preparation method therefor, and use thereof
05/03/2012WO2012055162A1 Momordica charantia polypeptide, preparation method therefor and use thereof
05/03/2012WO2012055066A1 Acarbose composition with effect of lowering blood glucose and preparation method thereof
05/03/2012WO2012032417A3 Compositions comprising a fatty acid oil mixture, a free fatty acid, and a statin
05/03/2012WO2012032415A3 Compositions comprising a fatty acid oil mixture comprising epa and dha in free acid form, a surfactant, and a statin
05/03/2012WO2012032414A3 Compositions comprising a fatty acid oil mixture, a surfactant, and a statin
05/03/2012WO2012031342A3 Polymer system and method for encapsulating human amylin and agonist analogues, and use thereof; released amylin functional evaluation method
05/03/2012WO2012023803A3 Composition for preventing and treating complications of diabetes mellitus, containing brandisia hancei hook. f. extract or fraction thereof as active ingredient
05/03/2012WO2012002777A3 Composition containing plant extracts for inhibiting the granule secretion of mast cells
05/03/2012WO2011133795A3 Beta-carbolines as inhibitors of haspin and dyrk kinases
05/03/2012WO2011122879A3 Composition comprising coumestrol or a bean extract containing coumestrol
05/03/2012US20120109051 Devices, methods, and kits for taste modification and controlling food intake
05/03/2012US20120108671 Cis 3,4-dihydroxy-2-(3-methylbutanoyl)-5-(3-methylbutyl)-4-(4-methylpentanoyl)cyclopent-2-en-1-one derivatives, substantially enantiomerically pure compositions and methods
05/03/2012US20120108654 Compositions and methods for the treatment of ocular oxidative stress and retinitis pigmentosa
05/03/2012US20120108639 Nitrogen-containing aromatic heterocyclyl compound
05/03/2012US20120108631 Sulfonamides for the Modulation of PKM2
05/03/2012US20120108619 N1/n2-lactam acetyl-coa carboxylase inhibitors
05/03/2012US20120108611 5, 6-bisaryl-2-pyridine-carboxamide derivatives, preparation and application thereof in therapeutics as urotensin ii receptor antagonists
1 ... 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 ... 1298